US Patent Issued to ABELZETA on May 27 for "Bispecific chimeric antigen receptors targeting CD20 and BCMA" (Maryland Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,022, issued on May 27, was assigned to ABELZETA INC. (Rockville, Md.).

"Bispecific chimeric antigen receptors targeting CD20 and BCMA" was invented by Yihong Yao (Rockville, Md.), Jiaqi Huang (Rockville, Md.), Shigui Zhu (Rockville, Md.), Xin Yao (Rockville, Md.), Xiaobing Luo (Rockville, Md.) and Yutian Wei (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides bispecific chimeric antigen receptors targeting CD20 and BCMA. The CAR may comprise an scFv targeting CD20 and an scFv targeting BCMA, a hinge region, a transmembrane domain, a co-stimulatory region, and a cytoplasmic signaling domain. The chimeric ant...